Ⓐ
PeptiBrief
Regulatory label· 2019

VYLEESI (bremelanotide injection) prescribing information

U.S. Food and Drug Administration

FDA Prescribing Information

Evidence level
regulatory
Verification
verified

Summary

Official prescribing information for bremelanotide.

Limitations

Regulatory label applies only to the approved product and indication.

Linked peptides

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.